More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Experts in cancer care have raised concern about the increasing intake of alcohol and tobacco use among young Nigerians, saying both have been identified as risk factors for breast cancer in younger ...

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Although Nor Haryati has finished her treatment, doctors were loathe to say she was cancer-free due to the genetic mutation.

Precision oncology is a cancer treatment approach that considers individual genetics, environmental exposures, and lifestyle factors to tailor the most ...

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

Tetravalent death receptor 5 (DR5) agonist ozekibart (INBRX-109) + FOLFIRI in 2L+ colorectal adenocarcinoma (CRC): Preliminary results from a phase 1 study. This is an ASCO Meeting Abstract from the ...

Integrating pharmacogenetic testing in the management of gastrointestinal cancers. A protocol for pretreatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab ...

Scientists from a collaboration of Australian research institutions have proposed that editing multiple genetic variants in human embryos could significantly lower the likelihood of developing ...

Their findings, published in Nature Aging, describe a never-before-seen link between the two most accepted explanations: random genetic mutations and predictable epigenetic modifications.